By Chris Wack
Bioventus shares were up 27% to $11.10 after the company reported a fourth-quarter that saw improvement over the same quarter last year.
The company said its quarterly loss narrowed to $156,000, or 0 cents a share, from a loss of $6.1 million, or 10 cents a share, last year. Adjusted earnings per share were 15 cents, up from 7 cents in the prior year.
Sales for the quarter rose to $153.6 million, compared to last year's $135.4 million.
Bioventus said fourth-quarter cash from operations was $19.3 million, up 86.3% from last year.
For 2025, the company is expecting sales of $560 million to $570 million, compared to $573.3 million in 2024. It is also expecting adjusted earnings of 64 cents to 68 cents a share.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
March 11, 2025 10:31 ET (14:31 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.